Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call

Written By Grant Lawson
Grant Lawson
Previous

SCHEDULE 14A Preliminary Proxy
Next

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences